参考文献/References:
[1] Haugen BR, Alexander EK, Bible KC, et al. 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer:The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer[J]. Thyroid, 2016, 26(1):1-133. DOI:10.1089/thy.2015.0020.
[2] Glazer DI, Brown RK, Wong KK, et al. SPECT/CT evaluation of unusual physiologic radioiodine biodistributions:pearls and pitfalls in image interpretation[J]. Radiographics, 2013, 33(2):397-418. DOI:10.1148/rg.332125051.
[3] 余永利, 陈泽泉, 高秀丽, 等. 分化型甲状腺癌131I全身扫描中消化系统131I摄取分析[J]. 肿瘤学杂志, 2011, 17(9):669-672. Yu YL, Chen ZQ, Gao XL, et al. Analysis of 131I uptake of digestive system in 131I whole body scan for differentiated thyroid carcinoma[J]. J Chin Oncol, 2011, 17(9):669-672.
[4] Riesco-Eizaguirre G, Santisteban P. A perspective view of sodium iodide symporter research and its clinical implications[J]. Eur J Endocrinol, 2006, 155(4):495-512. DOI:10.1530/eje.1.02257.
[5] Chudgar AV, Shah JC. Pictorial Review of False-Positive Results on Radioiodine Scintigrams of Patients with Differentiated Thyroid Cancer[J]. Radiographics, 2017, 37(1):298-315. DOI:10.1148/rg.2017160074.
[6] 陈可靖. 甲状腺癌131I显像假阳性的分析及鉴别诊断[J]. 国外医学放射医学核医学分册, 2000, 24(1):11-14. Chen KJ. The analysis and diferentiate diagnosis of false positive 131I imaging in metastatic thyroid carcinoma[J]. Foreign Med Sci (Sect Radiat Med Nucl Med), 2000, 24(1):11-14.
[7] 王叙馥, 张勤, 刘新峰, 等. 分化型甲状腺癌术后胸腺浓聚131I的临床分析[J]. 标记免疫分析与临床, 2014, 21(5):525-527, 531. DOI:10.11748/bjmy.issn.1006-1703.2014.05.009. Wang XF, Zhang Q, Liu XF, et al. Thymus Accumulation of Iodine-131 in Post-operative Patients with Differentiated Thyroid Cancer[J]. Labeled Immunoassays Clin Med, 2014, 21(5):525-527, 531. DOI:10.11748/bjmy.issn.1006-1703.2014.05.009.
[8] Connolly LP, Connolly SA. Thymic uptake of radiopharmaceuticals[J]. Clin Nucl Med, 2003, 28(8):648-651. DOI:10.1097/01.RLU.0000079388.43939.aa.
[9] 李镜发, 邹德环, 朱旭生, 等. 131碘全身显像双肺弥漫性显影1例[J]. 中国医学影像技术, 2005, 21(9):1352. DOI:10.3321/j.issn:1003-3289.2005.09.050. Li JF, Zou DH, Zhu XS, et al. Diffuse radioiodine lung uptake in 131 iodine whole body scan:case report[J]. Chin J Med Imaging Technol, 2005, 21(9):1352.
[10] 罗全勇, 陈立波, 余永利, 等. 分化型甲状腺癌131Ⅰ治疗后扫描的假阳性分析[J]. 中国医学影像技术, 2004, 20(12):1930-1932. DOI:10.3321/j.issn:1003-3289.2004.12.040. Luo QY, Chen LB, Yu YL, et al. Clinical analysis of false positive 131Ⅰ therapeutic scan in differentiated thyroid cancer[J]. Chin J Med Imaging Tech nol, 2004, 20(12):1930-1932. DOI:10.3321/j.issn:1003-3289.2004.12.040.
[11] Triggiani V, Giagulli VA, Iovino M, et al. False positive diagnosis on(131) iodine whole-body scintigraphy of differentiated thyroid cancers[J]. Endocrine, 2016, 53(3):626-635. DOI:10.1007/s12020-015-0750-3.
[12] Seok JW, Kim SJ, Kim IJ, et al. Normal gallbladder visualization during post-ablative iodine-131 scan of thyroid cancer[J]. J Korean Med Sci, 2005, 20(3):521-523. DOI:10.3346/jkms.2005.20.3.521.
[13] Carlisle M, Cortes A, Mcdougall IR. Uptake of 131I in the biliary tract:a potential cause of a false-positive result of scintiscan[J]. Clin Nucl Med, 1998, 23(8):524-527.
[14] 余永利, 柴红, 陈泽泉, 等. 分化型甲状腺癌131Ⅰ治疗后全身扫描腰-腹部131Ⅰ摄取分析[J/OL]. 中华临床医师杂志(电子版), 2012, 6(9):182-183[2017-10-30]. http://med.wanfangdata.com.cn/Paper/Detail?id=PeriodicalPaper_zhlcyszz201209054. DOI:10.3877/cma.j.issn.1674-0785.2012.09.054. Yu YL, Chai H, Chen ZQ, et al. Analysis of 131I uptake of abdominal cavity in post-therapy 131Ⅰ whole body scan for differentiated thyroid carcinoma[J/OL]. Clin J Clinicians(Electronic Edition), 2012, 6(9):2502-2504[2017-10-30]. http://med.wanfangdata.com.cn/Paper/Detail?id=PeriodicalPaper_zhlcyszz201209054.
[15] Lee M, Lee YK, Jeon TJ, et al. Frequent visualization of thyroglossal duct remnant on post-ablation 131I-SPECT/CT and its clinical implications[J]. Clin Radiol, 2015, 70(6):638-643. DOI:10.1016/j.crad.2015.02.018.
[16] Park SH, Seo M, Park TY, et al. An intrapericardial ectopic thyroid mimicking metastasis in a patient with papillary thyroid cancer:Localization, differential diagnosis by 18F-FDG PET/CT and ablation by 131Ⅰ[J]. Hell J Nucl Med, 2016, 19(3):272-274. DOI:10.1967/s002449910411.
[17] Kim HS, Kim SH, Kim JH, et al. Multifocal hot spots demonstrated by whole-body 131I scintigraphy and SPECT/CT after transaxillary endoscopic thyroidectomy[J]. Clin Nucl Med, 2015, 40(3):260-262. DOI:10.1097/RLU.0000000000000623.
[18] Isoda T, Baba S, Maruoka Y, et al. Nabothian cyst a predominant cause of false-positive iodine uptake in uterus:comparison of SPECT/CT and pelvic MRI[J]. Clin Nucl Med, 2014, 39(8):680-684. DOI:10.1097/RLU.0000000000000504.
[19] Nishiyama Y, Yamamoto Y, Takahashi K, et al. False-positive iodine-131 whole-body imaging due to gestational sac[J]. Clin Nucl Med, 1998, 23(8):535-536.
[20] 罗琼, 罗全勇, 陆汉魁, 等. 甲状腺癌131I治疗后扫描胆囊显影1例[J]. 中国医学影像技术, 2005, 21(10):1551. DOI:10.3321/j.issn:1003-3289.2005.10.060. Luo Q, Luo QY, Lu HK, et al. Gallbladder visualization during post-therapy 131-iodine imaging of thyroid carcinoma:case report[J]. Chin J Med Imaging Technol, 2005, 21(10):1551.
[21] Jia C, Moadel R, Freeman LM. Focal thoracic uptake mimicking lung metastasis on 131I post-therapy whole-body scan in patients with thyroid carcinoma[J]. Clin Nucl Med, 2014, 39(4):360-362. DOI:10.1097/RLU.0b013e31829959ce.
[22] Triggiani V, Moschetta M, Giagulli VA, et al. Diffuse 131I lung uptake in bronchiectasis:a potential pitfall in the follow-up of differentiated thyroid carcinoma[J]. Thyroid, 2012, 22(12):1287-1290. DOI:10.1089/thy.2011.0439.
[23] Thientunyakit T. False-positive 131I whole-body scan in well-differentiated thyroid cancer patient with respiratory bronchiolitis[J]. Clin Nucl Med, 2013, 38(9):730-734. DOI:10.1097/RLU.0b013e318286bbfa.
[24] Ozcan KP, Gunay EC, Erdogan A. Radioiodine Contamination Artifacts and Unusual Patterns of Accumulation in Whole-body 131I Imaging:A Case Series[J]. Int J Endocrinol Metab, 2014, 12(1):e9329. DOI:10.5812/ijem.9329.
[25] Licht K, Kroegel C, Katenkamp K, et al. Anthracofibrosis Manifesting as False-Positive Iodine Accumulation in a Patient With Recent History of Thyroid Carcinoma[J]. Clin Nucl Med, 2016, 41(4):336-337. DOI:10.1097/RLU.0000000000001074.
[26] Ranade R, Pawar S, Mahajan A, et al. Unusual False Positive Radioiodine Uptake on 131Ⅰ Whole Body Scintigraphy in Three Unrelated Organs with Different Pathologies in Patients of Differentiated Thyroid Carcinoma:A Case Series[J]. World J Nucl Med, 2016, 15(2):137-141. DOI:10.4103/1450-1147.176884.
[27] Yang J, Codreanu I, Servaes S, et al. Elevated iodine uptake at autogenous bone graft harvest sites[J]. Clin Nucl Med, 2012, 37(9):901-903. DOI:10.1097/RLU.0b013e31825b25a7.
[28] Strober MD, Callahan BR. Incidental 131Ⅰ Activity in the Deltoid Region on Posttherapy Radioiodine Scan[J]. Clin Nucl Med, 2017, 42(11):899-900. DOI:10.1097/RLU.0000000000001828.
[29] Lee WH, Park JM, Kwak JJ. A solitary large radioiodine accumulative lung lesion in high-dose 131i therapeutic scan:bronchial atresia with mucocele[J]. Clin Nucl Med, 2015, 40(2):149-152. DOI:10.1097/RLU.0000000000000477.
[30] Castillo-Berrio C, Zelaya F, Loira F, et al. Accumulation of 131Ⅰ Na activity in renal cysts unrelated to metastatic disease in a patient with differentiated thyroid cancer[J]. Rev Esp Med Nucl Imagen Mol, 2016, 35(1):70-71. DOI:10.1016/j.remn.2015.05.010.
[31] Campenni A, Ruggeri RM, Giovinazzo S, et al. Radioiodine uptake in a renal cyst mimicking a metastasis in a patient affected by differentiated thyroid cancer:case report and review of the literature[J]. Ann Nucl Med, 2014, 28(5):472-476. DOI:10.1007/s12149-014-0816-y.
[32] Jang HY, Kim BH, Kim WJ, et al. False-positive radioiodine uptake in a functional ovarian cyst in a patient treated with total thyroidectomy for papillary cancer[J]. Intern Med, 2013, 52(20):2321-2323. DOI:10.2169/internalmedicine.52.0786.
[33] Liu S, Zhang M, Pan Y, et al. Nabothian cyst associated with high false-positive incidence of iodine-131 uptake in whole-body scans after treatment for differentiated thyroid cancer[J]. Nucl Med Commun, 2013, 34(12):1204-1207. DOI:10.1097/MNM.0b013e328365911a.
[34] Bural GG, Peel RL, Mountz JM. Benign epithelial cyst mimicking thyroid cancer metastasis:a false-positive finding on post-therapy 131Ⅰ scan[J]. Clin Nucl Med, 2012, 37(1):88-90. DOI:10.1097/RLU.0b013e31822920a3.
[35] Yazici B, Oral A, Eraslan C, et al. False-Positive 131I Uptake in a Benign Bone Lesion on Post-therapy Scan[J]. Clin Nucl Med, 2016, 41(1):e63-e65. DOI:10.1097/RLU.0000000000000922.
[36] Sinha P, Conrad GR, Holzhauer M. Incidental detection of a falx meningioma on post-therapy radioiodide whole-body imaging[J]. Clin Nucl Med, 2002, 27(12):916-917.
[37] Bulzico D, Vaisman F, Cordeiro de Noronha Pessoa CH, et al. Cavernous angioma mimicking a differentiated thyroid carcinoma brain metastasis[J]. Clin Nucl Med, 2011, 36(1):62-63. DOI:10.1097/RLU.0b013e3181feefc2.
[38] Broekhuizen-De GH, van Isselt H, Roef M, et al. Oncocytoma of the parotid gland causing false-positive result on 131I whole-body scintigraphy[J]. Clin Nucl Med, 2011, 36(8):701-703. DOI:10.1097/RLU.0b013e318217a65f.
[39] Zhang Y, Minoshima S. SPECT/CT demonstrating 131I retention in Warthin tumor on thyroid cancer survey scan[J]. Clin Nucl Med, 2013, 38(9):e372-e373. DOI:10.1097/RLU.0b013e3182817ac5.
[40] Meyer M, Godbert Y, Soubeyran I, et al. Benign cystic mesothelioma:false-positive iodine accumulation in a patient with oncocytic follicular thyroid carcinoma[J]. Clin Nucl Med, 2014, 39(9):e395-e397. DOI:10.1097/RLU.0b013e3182a75664.
[41] Karyagar S, Uyanik E, Mulazimoglu M, et al. Uptake of 131I on a post thyroid ablation whole body scan, due to cavernous liver hemangioma, mimicking metastases[J]. Hell J Nucl Med, 2009, 12(2):177-178.
[42] Yoon S, Soo HI. Ovarian teratoma mimicking metastasis on 131I scan:a case report[J]. Nucl Med Mol Imaging, 2013, 47(1):52-54. DOI:10.1007/s13139-012-0167-3.
[43] 夏伟, 余永利, 罗全勇, 等. 分化型甲状腺癌131I全身显像卵巢黏液性囊腺瘤显影1例[J]. 中国医学影像技术, 2006, 22(3):478. DOI:10.3321/j.issn:1003-3289.2006.03.056. Xia W, Yu YL, Luo QY, et al. Benign mucous cystadenoma of the visualization during whole-body iodine 131 scan of differentiated thyroid carcinoma:a case report[J]. Chin J Med Imaging Technol, 2006, 22(3):478.
[44] Flug J, Lameka K, Lee R, et al. False-positive 131Ⅰ uptake by an ovarian serous cystadenofibroma[J]. Clin Nucl Med, 2012, 37(2):178-180. DOI:10.1097/RLU.0b013e31823933d2.
[45] Song HJ, Xue YL, Xu YH, et al. Abnormal 131Ⅰ uptake in a benign serous ovarian cystadenoma mimicking bladder physiological uptake[J]. Clin Nucl Med, 2012, 37(3):e59-e60. DOI:10.1097/RLU.0b013e31823ea982.
[46] Rachinsky I, Shelef I, Agranovich S, et al. Is osteoid osteoma an iodophilic lesion?:pathologically proved osteoid osteoma of nasal bone first seen on whole-body iodine-131 scan[J]. Clin Nucl Med, 2003, 28(8):696-698. DOI:10.1097/01.RLU.0000079434.68311.95.
[47] Lee M, Lee Y K, Jeon T J, et al. 131I uptake in intraosseous hemangioma of the skull:mimicking a bone metastasis in thyroid cancer[J]. Clin Nucl Med, 2014, 39(11):990-992. DOI:10.1097/RLU.0000000000000467.
[48] Naik C, Basu S. Mucoepidermoid Parotid Gland Tumor Found on Follow-up Radioiodine Scan for Differentiated Papillary Thyroid Cancer[J]. J Nucl Med Technol, 2017, 45(2):116-118. DOI:10.2967/jnmt.117.190777.
[49] Oh JR, Ahn BC. False-positive uptake on radioiodine whole-body scintigraphy:physiologic and pathologic variants unrelated to thyroid cancer[J]. Am J Nucl Med Mol Imaging, 2012, 2(3):362-385.
[50] Sohn MH, Kim MW, Lim ST, et al. Radioiodine uptake by metastatic nonthyroidal adenocarcinoma of the lung in a patient with papillary thyroid carcinoma[J]. Clin Nucl Med, 2005, 30(4):269-270.
[51] Ruel IF, Fierrard H, Vercellino L, et al. Pulmonary metastasis of struma ovarii:a case report[J]. Clin Nucl Med, 2010, 35(9):692-694. DOI:10.1097/RLU.0b013e3181e9fb1b.
[52] Anongpornjossakul Y, Utamakul C, Chamroonrat W, et al. Incidental Gallbladder Cancer Visualized From Posttreatment 131I Whole-Body Scan[J]. Clin Nucl Med, 2016, 41(3):e162-e163. DOI:10.1097/RLU.0000000000001019.
[53] Konez O, Hanelin LG, Jenison EL, et al. Functioning liver metastases on an 131I whole-body scan:a case of malignant struma ovarii[J]. Clin Nucl Med, 2000, 25(6):465-496.
[54] Cherng SC, Wang YF, Fan YM, et al. Malignant struma ovarii with peritoneal implants and pelvic structures and liver metastases demonstrated by I-131 SPECT and low-dose CT[J]. Clin Nucl Med, 2005, 30(12):797-798.
[55] Acar E, Akgun A, Kocacelebi K, et al. 131I uptake in malignant fibrous histiocytoma[J]. Clin Nucl Med, 2007, 32(7):580-581. DOI:10.1097/RLU.0b013e3180646a44.
[56] Sainz-Esteban A, de Luis RD, Garcia-Talavera SMP, et al. Incidental finding on a SPECT/CT of a retroperitoneal leiomyosarcoma imitating a hiatal hernia in 131I whole-body scan in thyroid cancer evaluation[J]. Rev Esp Med Nucl Imagen Mol, 2013, 32(6):406-407. DOI:10.1016/j.remn.2013.05.006.
[57] Ajmi S, Ben AK, Ben FM, et al. Tc-99m and I-131 uptake in widespread bone metastases from undetectable digestive adenocarcinoma[J]. Clin Nucl Med, 2011, 36(11):1020-1022. DOI:10.1097/RLU.0b013e318219b366.
[58] Ong SC, Eng DN, Sundram FX, et al. A novel case of false-positive 131I whole-body scan in thyroid carcinoma caused by subdural hematoma[J]. Clin Nucl Med, 2004, 29(3):164-166.
[59] Naddaf SY, Akisik MF, Omar WS, et al. 123Ⅰ uptake in the chest wall after needle biopsy of a pulmonary nodule. A cause for false-positive 123Ⅰ uptake[J]. Clin Nucl Med, 1997, 22(8):572-573.
[60] Regalbuto C, Buscema M, Arena S, et al. False-positive findings on 131I whole-body scans because of posttraumatic superficial scabs[J]. J Nucl Med, 2002, 43(2):207-209.
[61] Zhang M, Zhang Y, Huang W, et al. False-positive 131I uptake by the temporomandibular joint effusion[J]. Clin Nucl Med, 2013, 38(10):823-825. DOI:10.1097/RLU.0b013e3182a20dbf.
[62] Nascimento C, Bridji B, Dejax C, et al. Thoracic 131I uptake after previous pneumonectomy in patients treated for differentiated thyroid cancer[J]. Clin Nucl Med, 2012, 37(6):587-590. DOI:10.1097/RLU.0b013e3182485146.
[63] Zucker RJ, Bradley YC, Toney MO, et al. Gastric volvulus detected with iodine-131 whole-body imaging[J]. Clin Nucl Med, 2000, 25(4):303-305.
[64] Husmann L, Scheffel H, Stumpe K, et al. Pyelocaliceal diverticulum as a rare pitfall in 131I post-therapy scanning[J]. Clin Nucl Med, 2010, 35(6):443-444. DOI:10.1097/RLU.0b013e3181db4aa8.
[65] Mena BL, Vallejo CJ, Moreno OE, et al. 131Ⅰ visualization of thoracic aortic aneurysm after radioiodine administration for thyroid carcinoma[J]. Clin Nucl Med, 2008, 33(8):553-554. DOI:10.1097/RLU.0b013e31817deb95.
[66] Mattern M, Staab E. 131I localization in hematocolpos:a differential diagnosis consideration for pelvic 131I uptake[J]. Clin Nucl Med, 2007, 32(8):659-660. DOI:10.1097/RLU.0b013e3180a1ad35.
[67] Burlison JS, Hartshorne MF, Voda AM, et al. SPECT/CT localization of oral radioiodine activity:a retrospective study and in-vitro assessment[J]. Nucl Med Commun, 2013, 34(12):1216-1222. DOI:10.1097/MNM.0000000000000004.
[68] Winkens T, Nietzsche S, Gottschaldt M, et al. Nonspecific iodine accumulation in surgical suture material mimicking follicular thyroid cancer bone metastasis in 131I scintigraphy[J]. Clin Nucl Med, 2014, 39(2):209-210. DOI:10.1097/RLU.0000000000000297.
[69] Lv J, Qu Y, Zhang M, et al. Increased 131I accumulation in the polyacrylamide hydrophilic gel used for breast augmentation[J]. Clin Nucl Med, 2014, 39(4):415-416. DOI:10.1097/RLU.0000000000000391.
[70] Maruoka Y, Abe K, Baba S, et al. Incremental diagnostic value of SPECT/CT with 131I scintigraphy after radioiodine therapy in patients with well-differentiated thyroid carcinoma[J]. Radiology, 2012, 265(3):902-909. DOI:10.1148/radiol.12112108.
相似文献/References:
[1]梁雯丽,郑艳,李娜,等.Graves甲亢患者131I治疗后早期TRAb及TSAb变化的研究分析[J].国际放射医学核医学杂志,2016,40(1):13.[doi:10.3760/cma.j.issn.1673-4114.2016.01.003]
Liang Wenli,Zheng Yan,Li Na,et al.Analysis of the changes in early TRAb and TSAb after 131I treatment for patients with Graves hyperthyroidism[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(1):13.[doi:10.3760/cma.j.issn.1673-4114.2016.01.003]
[2]邓艳,张伟.125I-碘酞酸盐临床应用进展[J].国际放射医学核医学杂志,2016,40(3):225.[doi:10.3760/cma.j.issn.1673-4114.2016.03.012]
Deng Yan,Zhang Wei.125I-iothalamate clinical applications[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(1):225.[doi:10.3760/cma.j.issn.1673-4114.2016.03.012]
[3]田琦,蒋宁一,郑丽.265例精细个体化131I治疗Graves甲亢的疗效观察[J].国际放射医学核医学杂志,2016,40(4):259.[doi:10.3760/cma.j.issn.1673-4114.2016.04.004]
Tian Qi,Jiang Ningyi,Zheng Li.Therapeutic effect of fine individual 131I treatment on Graves disease hyperthyroidism[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(1):259.[doi:10.3760/cma.j.issn.1673-4114.2016.04.004]
[4]杨珂,唐波,于夕荣,等.甲状腺癌131i治疗病房的辐射屏蔽计算与评价[J].国际放射医学核医学杂志,2015,39(5):405.[doi:10. 3760 / cma. j. issn. 1673-4114. 2015. 05. 012]
yang ke,tang bo,yu xirong,et al.shielding calculation and assessment in 131i therapy for thyroid cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(1):405.[doi:10. 3760 / cma. j. issn. 1673-4114. 2015. 05. 012]
[5]徐蓉生,梅艳,赵力威,等.B超引导下术中125I粒子植入治疗晚期胰腺癌的疗效评价[J].国际放射医学核医学杂志,2016,40(6):424.[doi:10.3760/cma.j.issn.1673-4114.2016.06.005]
Xu Rongsheng,Mei Yan,Zhao Liwei,et al.Evaluation of 125I particle implantation in the treatment of patients with advanced pancreatic neoplasms using B ultrasound-guided surgery[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(1):424.[doi:10.3760/cma.j.issn.1673-4114.2016.06.005]
[6]王越,晋建华,李思进,等.甲状腺24h摄碘率与131I治疗Graves甲亢疗效相关性研究[J].国际放射医学核医学杂志,2015,39(6):442.[doi:10.3760/cma.j.issn.1673-4114.2015.06.002]
Wang Yue,Jin Jianhua,Li Sijin,et al.Correlation between thyroid 24 h of radioactive iodine uptake and clinical efficacy of 131I therapy for Graves’ hyperthyroidism[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(1):442.[doi:10.3760/cma.j.issn.1673-4114.2015.06.002]
[7]郭坤,高蕊,于燕,等.表皮生长因子受体基因表达与甲状腺功能亢进症131I治疗预后的关系[J].国际放射医学核医学杂志,2015,39(1):4.[doi:10.3760/cma.j.issn.1673-4114.2015.01.003]
Guo Kun,Gao Rui,Yu Yan,et al.The relationship between epidermal growth factor receptor mRNA expression and the efficacv of 131I treatment in hyperthyroidism patients[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(1):4.[doi:10.3760/cma.j.issn.1673-4114.2015.01.003]
[8]胡小春,蒋宁一,李敬彦,等.硒对经131I治疗Graves病患者血清甲状腺过氧化物酶抗体水平的影响[J].国际放射医学核医学杂志,2015,39(2):140.[doi:10.3760/cma.j.issn.1673-4114.2015.02.008]
Hu Xiaochun,Jiang Ningyi,Li Jingyan,et al.Effect of additional selenium on the levels of serum thyroid peroxidase antibody in patients with Graves disease treated with 131I[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(1):140.[doi:10.3760/cma.j.issn.1673-4114.2015.02.008]
[9]杨翠红,刘金剑,褚丽萍,等.125I标记注射用干扰素α2b(假单胞菌)研究雾化吸入与肌肉注射的代谢及组织分布差异[J].国际放射医学核医学杂志,2015,39(3):191.[doi:10.3760/cma.j.issn.1673-4114.2015.03.001]
Yang Cuihong,Liu Jinjian,Chu Liping,et al.Pharmacokinetics and tissue distribution of interferon α2b（Pseudomonas putida）administered via atomization inhalation and intramuscular injection by 125I labeling[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(1):191.[doi:10.3760/cma.j.issn.1673-4114.2015.03.001]
[10]陈雪梅,周树云,范源,等.表没食子儿茶素没食子酸酯对131I辐射损伤所致甲减大鼠模型抗氧化体系的保护作用[J].国际放射医学核医学杂志,2015,39(4):311.[doi:10.3760/cma.j.issn.1673-4114.2015.04.009]
Chen Xuemei,Zhou Shuyun,Fan Yuan,et al.Protection of antioxidant system of EGCG on the thyroid in rat model from 131I radiation damage[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(1):311.[doi:10.3760/cma.j.issn.1673-4114.2015.04.009]
[11]刘娇,程兵,常伟,等.非高危分化型甲状腺癌低剂量和高剂量131I清甲疗效的分析[J].国际放射医学核医学杂志,2016,40(6):419.[doi:10.3760/cma.j.issn.1673-4114.2016.06.004]
Liu Jiao,Cheng Bing,Chang Wei,et al.Ablation efficacy in non-high-risk differentiated thyroid carcinoma patients with low-dose and high-dose 131I[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(1):419.[doi:10.3760/cma.j.issn.1673-4114.2016.06.004]
[12]赵腾,梁军,林岩松.131I治疗前刺激性Tg在分化型甲状腺癌风险评估及治疗决策中的意义[J].国际放射医学核医学杂志,2015,39(1):61.[doi:10.3760/cma.j.issn.1673-4114.2015.01.013]
Zhao Teng,Liang Jun,Lin Yansong.The role of preablative stimulated thyroglobulin in guiding risk estimation and therapeutic decisions of differentiated thyroid carcinoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(1):61.[doi:10.3760/cma.j.issn.1673-4114.2015.01.013]
[13]钞卫光,张晶,陆克义.分化型甲状腺癌腹盆部131I显像假阳性分析[J].国际放射医学核医学杂志,2017,41(5):370.[doi:10.3760/cma.j.issn.1673-4114.2017.05.012]
Chao Weiguang,Zhang Jing,Lu Keyi.Analysis of differentiated thyroid cancer false-positive uptake in abdominal cavity and pelvic cavity on radioiodine whole-body scan[J].International Journal of Radiation Medicine and Nuclear Medicine,2017,41(1):370.[doi:10.3760/cma.j.issn.1673-4114.2017.05.012]
[14]孔维静,徐颖.综合干预措施下评估首次131I清甲治疗对分化型甲状腺癌患者唾液腺的慢性损伤[J].国际放射医学核医学杂志,2018,(1):30.[doi:10.3760/cma.j.issn.1673-4114.2018.01.006]
Kong Weijing,Xu Ying.Assessment of the chronic injury of salivary glands in patients with differentiated thyroid cancer who underwent comprehensive intervention measures with first 131I clearing therapy[J].International Journal of Radiation Medicine and Nuclear Medicine,2018,(1):30.[doi:10.3760/cma.j.issn.1673-4114.2018.01.006]